Scientists, doctors, and researchers are looking into why CBD (in particular, due to its non-psychoactive properties) makes an amazing, accessible treatment option.
The U.S. Drug Enforcement Agency (DEA) released a draft rule titled Controls to Enhance the Cultivation of Marihuana for Research in the United States,
The University of Notre Dame Australia’s Institute for Health Research (IHR) and MGC Pharma have announced publication of the study protocol for a clinical trial evaluating medical cannabis use with patients with dementia
CBD beauty companies are reeling from the sudden closure of brick-and-mortar retailers after heavily leaning on them in the past year.
The European Food Safety Authority (EFSA) has green-lighted the “suitability check” of an application from Czech-based phytocannabinoids maker CBDepot for synthetically manufactured Cannabidiol (CBD) as a Novel Food ingredient, the company announced.
Are you planning to purchase hemp oil or CBD oil soon? You might be surprised but these two are entirely different things.
With fewer antibiotics available to treat resistant bacterial infections, the possibility of entering a pre-antibiotic era is looming ahead.
Predictions for the domestic CBD market indicate growth to $20 billion by 2024, with a Nielsen study saying that the market will reach to somewhere between $2.25 billion and $2.75 billion in 2020, even accounting for some unpredictability in FDA rulings.
The U.S. Food and Drug Administration has updated its guidance for reporting adverse effects of various products, including dietary supplements, during the coronavirus pandemic.
Rats with regular access to cannabis seek more of the substance and tend to show increased drug-seeking behavior when cannabis is absent.